GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $522,016 (100.0% shares, 0.0% debt)

Holdings (33)

URGN UROGEN PHARMA LTD 9.3%
Value ($000) $48,767 Shares 2,906,259 Est. Cost $15.87 Unrealized -10.4%
NGNE NEUROGENE INC 7.0%
Value ($000) $36,546 Shares 1,004,291 Est. Cost $14.51 Unrealized +143.1%
ABVX ABIVAX SA 6.3%
Value ($000) $32,682 Shares 2,472,188 Est. Cost $12.06 Unrealized
MERUS N V 5.9%
Value ($000) $30,963 Shares 523,288 Est. Cost $52.47 Unrealized
PLRX PLIANT THERAPEUTICS INC 5.4%
Value ($000) $28,346 Shares 2,636,864 Est. Cost $16.18 Unrealized -20.3%
ACLX ARCELLX INC 5.2%
Value ($000) $27,153 Shares 492,000 Est. Cost $56.99 Unrealized -4.6%
DYNAVAX TECHNOLOGIES CORP 5.1%
Value ($000) $26,660 Shares 2,374,000 Est. Cost $11.86 Unrealized
EOLS EVOLUS INC 5.1%
Value ($000) $26,602 Shares 2,451,772 Est. Cost $9.65 Unrealized +27.4%
CYTK CYTOKINETICS INC 4.9%
Value ($000) $25,692 Shares 474,202 Est. Cost $51.75 Unrealized +16.6%
DNTH DIANTHUS THERAPEUTICS INC 3.8%
Value ($000) $19,615 Shares 757,929 Est. Cost $22.14 Unrealized +8.6%
INSM INSMED INC 3.2%
Value ($000) $16,750 Shares 250,000 Est. Cost $26.50 Unrealized +46.4%
ZURA ZURA BIO LTD 3.1%
Value ($000) $16,248 Shares 4,642,241 Est. Cost $6.43 Unrealized -36.6%
KALV KALVISTA PHARMACEUTICALS INC 3.0%
Value ($000) $15,768 Shares 1,338,568 Est. Cost $11.67 Unrealized 0.0%
IONS IONIS PHARMACEUTICALS INC 3.0%
Value ($000) $15,728 Shares 330,000 Est. Cost $41.01 Unrealized 0.0%
CNTX CONTEXT THERAPEUTICS INC 2.8%
Value ($000) $14,876 Shares 7,419,355 Est. Cost $1.72 Unrealized 0.0%
FOLD AMICUS THERAPEUTICS INC 2.8%
Value ($000) $14,835 Shares 1,495,500 Est. Cost $12.08 Unrealized -15.0%
OPTINOSE INC 2.7%
Value ($000) $14,276 Shares 13,727,097 Est. Cost $1.52 Unrealized
ESPR ESPERION THERAPEUTICS INC NE 2.5%
Value ($000) $12,857 Shares 5,791,594 Est. Cost $2.43 Unrealized -3.2%
VYGR VOYAGER THERAPEUTICS INC 2.4%
Value ($000) $12,668 Shares 1,601,527 Est. Cost $7.91 Unrealized
OTLK OUTLOOK THERAPEUTICS INC 2.4%
Value ($000) $12,557 Shares 1,701,510 Est. Cost $8.08 Unrealized -0.6%
AUTL AUTOLUS THERAPEUTICS PLC 2.3%
Value ($000) $11,977 Shares 3,441,667 Est. Cost $4.46 Unrealized
JSPR JASPER THERAPEUTICS INC 1.7%
Value ($000) $9,126 Shares 402,015 Est. Cost $17.76 Unrealized +35.0%
OLMA OLEMA PHARMACEUTICALS INC 1.7%
Value ($000) $8,622 Shares 796,880 Est. Cost $10.84 Unrealized 0.0%
TERN TERNS PHARMACEUTICALS INC 1.5%
Value ($000) $7,827 Shares 1,149,406 Est. Cost $5.81 Unrealized +4.3%
VRDN VIRIDIAN THERAPEUTICS INC 1.2%
Value ($000) $6,505 Shares 500,000 Est. Cost $19.39 Unrealized -28.6%
TCRX TSCAN THERAPEUTICS INC 1.1%
Value ($000) $5,504 Shares 940,831 Est. Cost $7.88 Unrealized 0.0%
VTGN VISTAGEN THERAPEUTICS INC 1.0%
Value ($000) $5,322 Shares 1,529,338 Est. Cost $3.78 Unrealized +14.4%
BBOT HELIX ACQUISITION CORP II 1.0%
Value ($000) $5,110 Shares 500,000 Est. Cost $10.35 Unrealized -0.6%
PBYI PUMA BIOTECHNOLOGY INC 0.9%
Value ($000) $4,846 Shares 1,486,544 Est. Cost $3.77 Unrealized +16.6%
KYTX KYVERNA THERAPEUTICS INC 0.7%
Value ($000) $3,744 Shares 499,152 Est. Cost $19.05 Unrealized -19.8%
SYRE SPYRE THERAPEUTICS INC 0.6%
Value ($000) $3,165 Shares 134,612 Est. Cost $15.20 Unrealized +121.9%
ANAB ANAPTYSBIO INC 0.1%
Value ($000) $627 Shares 25,000 Est. Cost $23.39 Unrealized -0.5%
LXRX LEXICON PHARMACEUTICALS INC 0.0%
Value ($000) $50 Shares 30,000 Est. Cost $1.79 Unrealized 0.0%